Antimicrobial Resistance is a Risk for Healthy Aging

It is estimated that, in the coming decades, ten million people will die each year as victims of microorganisms that antibiotics can no longer fight

What if the medicines we rely on to overcome infections are no longer able to protect us from known diseases that would become potentially fatal? Unfortunately, that’s what we’re about to see happen. About 700,000 people die each year as victims of antimicrobial resistance – which is when medicines stop working to fight microorganisms such as fungi, viruses or bacteria that have undergone genetic changes. In the coming decades, the estimate made by the United Nations (UN) is that this number will reach ten million. It’s good to repeat it.

Sepsis, a life-threatening organ dysfunction that is caused by an unregulated response to infections, kills 11 million a year, including 3 million children. The condition is more common in hospitalized patients, or who have been recently discharged, because the hospital environment, where the use of antibiotics is widespread, is almost a “nary” for superbacteria.

Article by Michael Hodin, CEO of the Global Coalition on Aging (organization focused on issues related to longevity), in partnership with Susan Wile Schwarz and Olivia Canie, states that although this is a global health problem, it has a disproportionate weight for older people:

“Forty percent of deaths in the United States caused by antibiotic-resistant pathogens occur in the group over 65 years of age. Diseases such as pneumonia and urinary tract infection, which often affect the elderly, are also those with strains of bacteria resistant to medication”.

In 1900, pneumonia, tuberculosis and gastrointestinal infections were among the leading causes of death in the USA. Between 1950 and 1970, there was a golden age for antibiotics. However, between 2000 and 2020, the Food and Drug Administration (the North American equivalent of Anvisa) saw a drop of almost 75% in medicines of this type submitted for its approval.

Scientific innovation in the area of antibiotics is on the decline and we need a new arsenal against infections. When a bacterium survives the treatment, this resistance passes to the next generation, until the existing drugs become innocuous. Multidrug-resistant tuberculosis is a problem in one hundred countries and about 500,000 people develop the disease annually.

The global scenario is a challenge of enormous proportions:

  1. At least 30% of antibiotics prescribed in the US are unnecessary.
  2. In Italy, the inappropriate use of antibiotics ranges from 33% for individuals under 45 years of age, to 51% for the elderly between 66 and 75 years of age.
  3. In China, 84% of pharmacies sell antibiotics without a prescription.
  4. Its use is expected to increase by 200% by 2030.
  5. Globally, the economic cost of antimicrobial resistance beats 100 trillion dollars per year.

(Translated from the original Portuguese)

Source: G1 Globo

Latest Developments

We keep our members and partners in touch with the most recent updates and opinions in the worldwide dialogue on population longevity and related issues.

Global Coalition on Aging, Leading G7 Government Officials, Call for Incentivized Antibiotic Innovation

The Global Coalition on Aging (GCOA), in partnership with the Japanese Pharmaceutical Manufacturer’s Association (JPMA), and public health leaders call on G7 governments to fund pull incentives and make “fair share” investments in antibiotic innovation to fight the global antimicrobial resistance (AMR) crisis. GCOA, JPMA, and health and government officials from the European Union, Italy, Japan, and United Kingdom recently convened to discuss how G7 countries must respond. GCOA today published a report detailing takeaways from the closed-door meeting, “The Role of G7 Governments in Global Efforts to Encourage Antimicrobial Development Through a Pull Incentive: Challenges and Collaboration.”

2024 AMR Preparedness Index Progress Report Highlights Urgent Need For Global Action Against Antimicrobial Resistance

Today, the Global Coalition on Aging (GCOA) and the Infectious Diseases Society of America (IDSA) launched the 2024 AMR Preparedness Index Progress Report. Released in the lead up to the United Nations General Assembly 2024 High-level Meeting on Antimicrobial Resistance (AMR) this September, the 2024 Progress Report assesses how the eleven largest global economies have advanced on calls to action laid out in the 2021 AMR Preparedness Index.

New Global Analysis Across Five Cities Shows Inequities in Adult Immunization Uptake, Signaling Need to Redesign Local and National Policy Interventions

GSK, in collaboration with the Global Coalition on Aging (GCOA), announced a new report from the IQVIA Institute for Human Data Science (IQVIA Institute). The report, funded by GSK, explores the role of social and structural determinants of health in adult vaccine access and uptake across five global cities with strong data about their aging populations: Bangkok, Thailand; Brussels, Belgium; Chicago, US; Manchester, United Kingdom; and New York City, US.

New Report From the Global Coalition on Aging Highlights the Connection Between Adult Immunization and Economic Health in Aging APEC Region

As leaders from across the Asia-Pacific Economic Cooperation (APEC) region convene in San Francisco over the next week, a new report from the Global Coalition on Aging (GCOA) points to investments in healthy aging as a growing economic imperative amid the region’s changing demographics. According to the new report, programs that keep populations healthy, active, and productive – like adult immunization – are increasingly becoming a prerequisite for economic stability and growth.

Menopause, the Silver Economy and Workplace Opportunities

As we recognise World Menopause Day, take a moment to consider the economic power, diverse expertise and skills, and incredible societal contributions of the estimated 1.1 billion post-menopausal women worldwide by 2025—a population on-par with China or India, and dwarfing any other country. Indeed, if we want to fuel the vibrant $15 trillion silver economy, societies, governments, and employers must empower older women in the future of work, including solutions that fight stigma and increase workplace support related to menopause.